Literature DB >> 7970556

Distance stereopsis in orthophores, heterophores, and intermittent strabismics.

R P Rutstein1, P Fuhr, D Schaafsma.   

Abstract

The purpose of this study was to investigate the value of clinical testing of distance stereopsis. Distance stereopsis was assessed with the Mentor Binocular Vision Testing System (B-VAT) system for 45 patients with ocular deviations of 6 delta or more at distance (heterophoria and intermittent strabismus) and for 36 patients with orthophoria. On the average, distance stereopsis was better for patients with the smaller ocular deviations than for those with the larger ocular deviations. The mean distance stereoacuities, both contour and global, for the orthophores were 53 and 81 sec arc, for the heterophores 93 and 100 sec arc, and for the intermittent strabismics 95 and 169 sec arc. Although the average size of the deviation at distance and near for the heterophoric and strabismic patients was nearly the same, distance stereopsis tended to be poorer than near stereopsis. There was a significant difference between the proportion of orthophores and the proportion of intermittent strabismics exhibiting distance stereopsis with both contour and global stereo targets (p < 0.05).

Entities:  

Mesh:

Year:  1994        PMID: 7970556     DOI: 10.1097/00006324-199407000-00001

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  3 in total

1.  Contribution of a real depth distance stereoacuity test to clinical management.

Authors:  B J Young; H Sueke; J M Wylie; S B Kaye
Journal:  J Ophthalmol       Date:  2009-07-05       Impact factor: 1.909

2.  Effects of Target Size and Test Distance on Stereoacuity.

Authors:  Yo Iwata; Fusako Fujimura; Tomoya Handa; Nobuyuki Shoji; Hitoshi Ishikawa
Journal:  J Ophthalmol       Date:  2016-08-21       Impact factor: 1.909

3.  Prevalence of Heterophoria in Tibetan Grade-One Students: The Lhasa Childhood Eye Study.

Authors:  Han Su; Jing Fu; Weiwei Chen; Zhaojun Meng; Lei Li; Wei Dai; Yao Yao
Journal:  J Ophthalmol       Date:  2020-12-24       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.